PRICE T ROWE ASSOCIATES INC /MD/ - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$105,983
+65.0%
2,433,029
+36.9%
0.02%
+77.8%
Q2 2023$64,224
-2.5%
1,777,579
+0.4%
0.01%
-10.0%
Q1 2023$65,844
+2.6%
1,770,941
+25.0%
0.01%0.0%
Q4 2022$64,191
-99.9%
1,416,728
+24.0%
0.01%
-23.1%
Q3 2022$79,811,000
+13.1%
1,142,755
+8.7%
0.01%
+44.4%
Q2 2022$70,589,000
-47.8%
1,051,530
-36.0%
0.01%
-35.7%
Q1 2022$135,187,000
-57.6%
1,644,216
-24.4%
0.01%
-51.7%
Q4 2021$319,021,000
-14.7%
2,174,799
+2.9%
0.03%
-17.1%
Q3 2021$374,025,000
+20.5%
2,114,210
+10.0%
0.04%
+20.7%
Q2 2021$310,425,000
+18.2%
1,921,779
+25.4%
0.03%
+11.5%
Q1 2021$262,517,000
-23.4%
1,532,500
-1.7%
0.03%
-25.7%
Q4 2020$342,510,000
+57.3%
1,559,416
+18.9%
0.04%
+40.0%
Q3 2020$217,735,000
+45.7%
1,311,262
+0.2%
0.02%
+31.6%
Q2 2020$149,432,000
+51.0%
1,308,852
+1.6%
0.02%
+18.8%
Q1 2020$98,981,000
-44.6%
1,287,645
-7.1%
0.02%
-30.4%
Q4 2019$178,520,000
+71.4%
1,385,379
+3.7%
0.02%
+53.3%
Q3 2019$104,132,000
-16.2%
1,336,564
+10.8%
0.02%
-11.8%
Q2 2019$124,233,000
+107.3%
1,206,144
+47.5%
0.02%
+88.9%
Q1 2019$59,932,000
+329.2%
817,628
+148.4%
0.01%
+350.0%
Q4 2018$13,963,000
-9.6%
329,160
+0.3%
0.00%0.0%
Q3 2018$15,450,000
+47.5%
328,024
+54.4%
0.00%0.0%
Q2 2018$10,475,000
+83.1%
212,465
+14.0%
0.00%
+100.0%
Q1 2018$5,720,000186,3200.00%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$136,602,67987.83%
EcoR1 Capital, LLC 5,748,399$250,400,2608.45%
Boxer Capital, LLC 3,201,440$139,454,7267.42%
RTW INVESTMENTS, LP 6,768,514$294,836,4706.22%
Paradigm Biocapital Advisors LP 1,668,116$72,663,1334.93%
Avoro Capital Advisors LLC 6,666,666$290,399,9714.53%
Octagon Capital Advisors LP 655,051$28,534,0224.38%
Artal Group S.A. 2,024,226$88,1753.78%
Ally Bridge Group (NY) LLC 70,283$3,061,5273.59%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 216,000$9,404,6403.17%
View complete list of MIRATI THERAPEUTICS INC shareholders